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The solute carrier SLC4 family consists of 10 members, nine of which are HCO−3
transporters, including three Na+-independent Cl−/HCO− exchangers AE1, AE2, and3
AE3, five Na+-coupled HCO− transporters NBCe1, NBCe2, NBCn1, NBCn2, and3
NDCBE, as well as “AE4” whose Na+-dependence remains controversial. The SLC4
HCO− transporters play critical roles in pH regulation and transepithelial movement of3
electrolytes with a broad range of demonstrated physiological relevances. Dysfunctions
of these transporters are associated with a series of human diseases. During the
past decades, tremendous amount of effort has been undertaken to investigate the
topological organization of the SLC4 transporters in the plasma membrane. Based
upon the proposed topology models, mutational and functional studies have identified
important structural elements likely involved in the ion translocation by the SLC4
transporters. In the present article, we review the advances during the past decades
in understanding the structure and function of the SLC4 transporters.
Keywords: bicarbonate transporter, solute carrier, acid-base balance, topology structure, alternative splicing,
metabolic acidosis, cysteine scanning mutagenesis, N-glycosylation
INTRODUCTION
It is fundamentally important to maintain acid-base homeostasis in the body. The solute
carrier 4 (SLC4) family represents a major group of bicarbonate transporters. In mammals, the
SLC4 family consists of 10 genes. Except for SLC4A11 encoding BTR1 which likely mediates
electrogenic Na+-coupled borate transport (Parker et al., 2001; Park et al., 2004) and/or
electrogenic NH3/H+ cotransport (Ogando et al., 2013; Zhang et al., 2015; for review, see
Patel and Parker, 2015), the other nine (SLC4A1-5 and SLC4A7-10) encode HCO−3 transporters
that are either Na+-independent or Na+-dependent (Figure 1). The Na+-independent members
include three well characterized anion exchangers (AEs) AE1 (SLC4A1), AE2 (SLC4A2), and
AE3 (SLC4A3) conducting electroneutral transmembrane exchange of Cl− and HCO−3 . The
Na+-dependent members, commonly known as Na+-coupled HCO−3 transporters (NCBTs),
include two electrogenic Na+/HCO−3 cotransporters NBCe1 (SLC4A4) and NBCe2 (SLC4A5), two
electroneutral Na+/HCO−3 cotransporters NBCn1 (SLC4A7) and NBCn2 (SLC4A10), as well as
an electroneutral Na+-driven Cl−/HCO−3 exchanger NDCBE (SLC4A8). The Na
+-dependence of
“AE4” (SLC4A9) remains controversial. Several groups have shown evidences that the product
of SLC4A9 performs Cl−/HCO−3 exchange (Tsuganezawa et al., 2001; Ko et al., 2002; Xu et al.,
2003). However, Parker et al., observed in a preliminary study that human AE4 mediates Na+-
dependent HCO−3 transport rather than Na
+-independent Cl−/HCO−3 exchange (Parker et al.,
2002). As shown in Figure 1 and Table 1, the amino acid sequence of “AE4” is more closely
related to those of the electrogenic NCBTs. Indeed, on the genomic level, the gene structure
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FIGURE 1 | Phylogenetic tree of SLC4 family. A multiple sequence alignment was performed with human sequences of eAE1 (NP_000333.1), AE2a
(NP_003031.3), bAE3 (NP_005061.2), AE4a (NM_031467), NBCe1-A (AAC51645.1), NBCe2-c (AAK97072.1), NBCn1-E (ACH61961), NBCn2-A (NP_071341.2),
NDCBE-A (AAY79176), and BTR1 (NP_114423) with the online software Clustal Omega from the European Bioinformatics Institute. The unrooted phylogenetic tree
was generated by using Treview based on the sequence alignment (Page, 1996).
TABLE 1 | Identities of TMD among SLC4 family HCO−
3
transporters.
AE2 AE3 AE4 NBCe1 NBCe2 NBCn1 NBCn2 NDCBE
AE1 73.2 67.7 42.4 44.1 42.5 42.2 42.2 42.2
AE2 71.8 44.6 45.2 42.6 42.9 42.7 43.3
AE3 44.7 44.9 43.1 44.2 43.4 43.2
AE4 62.9 59.1 53.7 53.7 53.7
NBCe1 72.3 57.4 59.8 59.8
NBCe2 52.0 56.7 55.1
NBCn1 81.5 81.5
NBCn2 84.4
Amultiple sequence alignment was performedwith the TMDs of human SLC4 transporters
by using the online Clustal Omega from the European Bioinformatics Institute. Note the
colors denoting the groups of relatedness among the TMDs of different SLC4 family HCO−3
transporters. The AEs share about 70% identities with each other. The AEs share 42-45%
identities with “AE4” and the NCBTs. The electrogenic NBCe1 and NBCe2 share 72%
identity with each other, and they share 52-60% identities with the electroneutral NCBTs.
The electroneutral NCBTs share more than 81% identities with each other. Note that, the
TMD of “AE4” is most closely related to those of the electrogenic NCBTs.
(e.g., the exon boundaries) of SLC4A9 is more similar to those of
SLC4A4 and SLC4A5 than to those of the three AEs (see review
by Parker and Boron, 2013).
The HCO−3 transporters of SLC4 family are broadly expressed
in the body, playing fundamental roles in intracellular and
extracellular pH regulation as well as transepithelial secretion
and absorption of HCO−3 and other electrolytes (e.g., Na
+ and
Cl−) in diverse tissues. The pH regulation and transepithelial
ion transport mediated by these transporters are critical for a
diverse range of biological processes and functions in the body,
such as modulation of neuronal excitability (Hentschke et al.,
2006; Jacobs et al., 2008; Sinning et al., 2011, 2015), maintenance
of corneal transparency (Suzuki et al., 2012), maintenance of
systemic acid-base homeostasis by the kidney (Romero and
Boron, 1999; Guo et al., 2014; Kurtz, 2014), digestion-related
function of the liver, the pancreas, and the duodenum (Uriarte
et al., 2010; Chen et al., 2012; Park and Lee, 2012; Novak
et al., 2013), regulation of vascular tone (Boedtkjer et al.,
2011), development of dental enamel (Lacruz et al., 2010), bone
remodeling (Riihonen et al., 2010), spermiogenesis (Medina
et al., 2003; Liu et al., 2012), etc. (for review, see Alper, 2009;
Boron et al., 2009; Park and Lee, 2012; Parker and Boron, 2013;
Romero et al., 2013). Dysfunctions of these transporters are
associated with a broad spectrum of pathological conditions,
including central nervous system diseases (such as mental
retardation, migraine, epilepsy, autism, drug addiction) (Sander
et al., 2002; Demirci et al., 2006; Sebat et al., 2007; Gurnett
et al., 2008; Krepischi et al., 2010; Suzuki et al., 2010), visual
abnormalities (including cataracts, band keratopathy, glaucoma,
retina degeneration) (Igarashi et al., 1999; Suzuki et al., 2010;
Kao et al., 2011), cardiovascular disease (e.g., hypertension)
(Barkley et al., 2004; Hunt et al., 2006; Ehret et al., 2011; Taylor
et al., 2013; Wen et al., 2015a), red cell disorders (such as
hemolytic anemia and Southeast Asian ovalocytosis) (Imamura
et al., 1984; Jarolim et al., 1991), proximal and distal renal
tubular acidosis (Bruce et al., 1997; Igarashi et al., 1999; Shayakul
and Alper, 2004; Suzuki et al., 2010; Wen et al., 2015b), bone
dysplasia (Lo et al., 2011), breast cancer (Ahmed et al., 2009;
Antoniou et al., 2010; Mulligan et al., 2011; Lee et al., 2015),
infertility (Medina et al., 2003), etc. (for review, see Alper,
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2009; Parker and Boron, 2013; Romero et al., 2013; Guo et al.,
2014).
Readers are referred to the latest reviews for the physiology,
pathology, and the functional regulation of the SLC4 HCO−3
transporters (Parker and Boron, 2013; Romero et al., 2013;
Thornell and Bevensee, 2015). In the present article, we will
provide an extensive review on the progresses during the past
decades about the structure and function of the SLC4 family
HCO−3 transporters.
TOPOLOGICAL ORGANIZATION OF SLC4
TRANSPORTERS
The SLC4 family transporters are N-glycosylated integral
membrane proteins. The lengths and molecular weights of the
polypeptides vary greatly among different members of the SLC4
family and even different variants of a same member. The lengths
of the entire polypeptide of different SLC4 members vary from
∼850 to 1250 amino acids (aa). The apparent molecular weights
of the native SLC4 transporters, mostly with oligosaccharide
moieties, range from about 90 to 200 kDa (Fairbanks et al., 1971;
Tanner and Boxer, 1972; Schmitt et al., 1999; Praetorius et al.,
2004a,b; Hentschke et al., 2006; Chen et al., 2007, 2008a,b; Kao
et al., 2011).
As shown in Figure 2, the entire polypeptides of the SLC4
transporters contain threemajor domains: (1) a large intracellular
amino-terminal (Nt) domain varying from ∼300 to 700 aa in
length; (2) a multiple-spanning transmembrane domain (TMD)
of ∼500 aa in length; (3) a small intracellular carboxyl-terminal
(Ct) domain of∼40-130 aa in length.
The gross orientation, i.e., the intracellular localization of
the Nt and Ct domains, of the polypeptides of the SLC4
family transporters has been determined largely based upon
the work with AE1, the first member identified in the SLC4
family. AE1 is also known as band 3, meaning the third
major band with molecular weight of about 95 kDa on sodium
dodecyl sulfate polyacrylamide gel electropheresis (SDS-PAGE)
of the membrane proteins from erythrocytes. AE1 is extremely
abundant in erythrocytes, accounting for 25-30% of total proteins
in the plasma membrane (Fairbanks et al., 1971; Tanner and
Boxer, 1972). The extremely high abundance of AE1 makes
the erythrocyte membrane a good system for determining the
membrane orientation of AE1 in the early history of studies in
the field.
Intracellular Localization of Nt Domain
In the 1970s, considerable number of studies were carried out
with AE1 by classical biochemical approaches to establish the
intracellular localization and the gross size of the Nt domain of
FIGURE 2 | Putative models of topological organization of SLC4 transporters (A,B) and 3D crystal structure of Nt domain of AE1 (C). For the
convenience to compare the sequence assignments, both topological models A and B use human NBCe1-A for illustration. The numbers (according to accession
#AAC51645.1) at both ends of each putative TM indicate the proposed initial and last residues of the TM in each model. Experimentally, model A is largely based on
the studies with AE1 by N-glycosylation scanning mutagenesis (Popov et al., 1997, 1999) and cysteine scanning mutagenesis (Tang et al., 1998; Zhu et al., 2003).
The front half of TMD (TM1-TM9) of model B is basically consistent with model A except for some minor deviations in the boundaries of TMs. The assignment of the Ct
half from EL5-TM14 in model B is based upon the cysteine-scanning mutagenesis study on NBCe1 (Zhu et al., 2010a,b) and the structural modelings with AE1
(Barneaud-Rocca et al., 2013; Bonar et al., 2013). Panel C shows the 3D structure of the dimer of the Nt domain of human AE1. The model was created based on the
crystal structure of the Nt of human AE1 (PDB ID #4KY9) using Protein Workshop 4.2.0 from RCSB Protein Data Bank (Moreland et al., 2005). The hydrophobicity
surface (blue least, red most) was generated by using a Euclidean Distance Transform (Xu and Zhang, 2009).
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AE1 in erythrocytes (Drickamer, 1976, 1977, 1978; Lepke and
Passow, 1976; Steck et al., 1976; Grinstein et al., 1978). In these
studies, the AE1 protein in entact erythrocytes or membrane
ghosts was often labeled with either radioactive reagents
or specific non-radioactive chemicals and then fragmented
by in situ protease digestion (e.g., with chymotrypsin,
pronase, or trypsin) or specific chemical degradation (e.g.,
2-nitro-5-thiocyanobenzoic acid, hydroxylamine, or N-
bromosuccinimide). The intracellular localization of the Nt
end was determined by a series of comprehensive biochemical
analyses with the fragments of AE1.
Notably, extracellular treatment with chymotrypsin to entact
erythrocytes splits the AE1 protein of ∼95 kDa into two
fragments with a molecular weight of about 65 and 30 kDa,
respectively (Drickamer, 1976, 1978). The 65-kDa fragment
share a same terminus with the entact 95-kDa polypeptide
of AE1 (Drickamer, 1976). Moreover, as determined by
carboxypeptidase digestion, this 65-kDa fragment has a different
carboxyl terminus compared to the entact 95-kDa polypeptide
of AE1. Therefore, it is concluded that the 65-kDa fragment
represents the Nt portion of AE1 (Drickamer, 1976). Proteolytic
digestion of trypsin with inside-out vesicles of erythrocytic
membrane can further split the above 65-kDa fragment into
a water-soluble component of ∼41 kDa plus an integral
component of ∼17 kDa remaining in the membrane vesicle
(Steck et al., 1976; Grinstein et al., 1978). Consistent with this
last observation, limited trypsin digestion of the entact AE1 in
human red cell ghost membranes results in an integral fragment
of ∼55 kDa which has an identical carboxyl terminus with
the entact AE1 polypeptide as determined by carboxypeptidase
digestion (Lieberman et al., 1987). Taken together, these studies
demonstrate that the Nt domain resides in the cytoplasmic side
as a soluble globular structure.
Recombinant expression and crystallography studies on the
isolated Nts of AE1 and NBCe1 have demonstrated that the Nt
domains of these transporters indeed have a globular structure
(Zhang et al., 2000; Gill and Boron, 2006). Single particle electron
microscopy study with the full-length AE1 shows that the Nt
domain is connected to the TMD by a highly flexible linker
(Figure 3; see Jiang et al., 2013).
Intracellular Localization of Ct Domain
The intracellular localization of the Ct domain of the SLC4
transporters was established by biochemical and immunological
studies with AE1 in the late 1980s. Biochemical study showed
that the carboxyl terminus of AE1 from human erythrocytes is
subjected to the digestion of carboxypeptidase Y only from the
cytoplasmic side of the membrane (e.g., with inside-out vesicles),
but not on entact red blood cells, suggesting that the Ct domain
of AE1 is located in the intracellular side (Lieberman et al., 1987).
By immunobinding assay with polyclonal antibody against the
extreme Ct end of murine AE1, the Ct end of AE1 is accessible
just from the cytoplasmic side of red cell membrane (Lieberman
and Reithmeier, 1988). For example, inside-out vesicles of
erythrocyte membrane, but not entact cells, are competitive
to the binding of the antibody to the immunogen in enzyme
linked immunosorbent assays (ELISA). The observation was
confirmed by a study on human AE1 with monoclonal antibodies
(Wainright et al., 1989). One of those monoclonal antibodies
reacts with an epitope on the intracellular side of the plasma
membrane of erythrocytes. Moreover, this epitope is extremely
sensitive to the treatment by carboxypeptidase Y, suggesting
that the epitope recognized by the monoclonal antibody is not
protected by the membrane, which is consistent with the notion
that the Ct end of AE1 is in the aquesous environment on the
intracellular side.
Topology Structure of TMD
It has been more than four decades since the identification
of AE1, the first identified member of SLC4 family, from
the erythrocytes. However, the fine three-dimensional structure
of the TMD of AE1 or any other SLC4 family members
remains unknown. Although several 3D structures of AE1 have
been reported from cryo-electron microscopy (cryo-EM) studies
FIGURE 3 | 3D structure model of human AE1 dimers obtained by cryo-EM. Shown here are two potential organizations of the AE1 dimers: twisted (left) and
parallel (right). The two molecules of AE1 are shown in different color. The figures are modified from Jiang et al. (2013).
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(Wang et al., 1994; Yamaguchi et al., 2010a,b; Jiang et al., 2013),
the resolutions of these cryo-EM structures are too low to
determine the topology of the TMD. Our current knowledge
about the topology of the TMD of SLC4 transporters is largely
derived from a series of biochemical studies on AE1 and NBCe1.
Since both the Nt and Ct domains are located in the
intracellular side of the cytoplasmic membrane, it is obvious
that the polypeptide of the SLC4 family transporters must span
the membrane an even number of times. The cDNA of AE1
was first cloned from murine erythrocytes (Kopito and Lodish,
1985). Based on a hydropathy analysis with the primary amino-
acid sequences deduced from this cDNA, the TMD of AE1 is
predicted to span the cytoplasic membrane for at least 12 times
(Kopito and Lodish, 1985). Since the 1980s, treandous number of
undertakings have been made with AE1 and NBCe1 to determine
the topology of the TMD of the SLC4 family transporters.
These include biochemical studies based upon in situ proteolytic
digestion (Hamasaki et al., 1997), cysteine scanning mutagenesis
(Tang et al., 1998, 1999; Fujinaga et al., 1999; Zhu et al., 2003,
2010a,b), N-glycosylation mutagenesis (Popov et al., 1997, 1999;
Cheung et al., 2005; Chen et al., 2011) as well as homology
modeling (Barneaud-Rocca et al., 2013; Bonar et al., 2013).
Based upon the above studies, multiple different models have
been proposed for the TMD topology of the SLC4 transporters.
Generally, it has been agreed in the field that the polypeptides
of the SLC4 family transporters contain 14 transmembrane
segments (TMs). However, there is a major discrepancy among
different models regarding the number of transmembrane alpha
helices in the TMDs. Some models propose that the TMD
contains 13 transmembrane helices (e.g., Zhu et al., 2003; Parker
and Boron, 2013), whereas some models propose that the TMD
contains 14 transmembrane helices (e.g., Popov et al., 1997; Zhu
et al., 2010a,b).
Figure 2 summarizes the main features of two models
emerged so far about the TMD topology of the SLC4 transporters.
In model A, 13 of the 14 TMs (except for TM12) are predicted
to be helical, whereas all 14 TMs in model B are predicted to
be helical. The sequence assignment and orientation for TMs 1-9
and 13-14 are generally in agreement with each other in the two
models, although minor differences exist regarding the precise
lengths and sequence boundaries of the TMs.
Two major differences exist beween the two models for the
regions between TM9 and TM13. First, the re-entrant loop
RL1 (region 797-828) between TM9 and TM10 in model A
is proposed to form a transmebrane helix (TM10) and an
intracellular loop (IL5) in model B. Therefore, TM10 and TM11
in model A would correspond to, but be in the opposite direction
with, TM11 and TM12 in model B, respectively. Second, the re-
entrant loop RL2 (TM12) which is proposed to be non-helical in
model A is mostly assigned to the 6th intracellular loop (IL6) in
model B.
The differences in the two models reflect inconsistencies
among the experimental data from different groups. Regarding
“RL1” in model A, cysteine residues introduced in region
813-828 of NBCe1-A are highly sensitive to labeling by
membrane permeant sulfhydryl reagent biotin maleimide
(BM), but are not accessible to membrane impermeant
MTS-TAMRA [2-((5(6)-tetramethylrhodamine) carboxylamino)
ethyl methanethiosulfonate], consistent with the idea that this
region is localized in the intracellular aquaeous environment
(Zhu et al., 2010a). A consequence of this localization is that
the following TM should be oriented outward, as shown in
model B. Two additional lines of observations are consistent
with this hypothesis: (1) Met858 in NBCe1-A is accessible to
chemical labeling by BM andMTS-TAMRA (Zhu et al., 2010a,b),
consistent with an extracellular localization of this position; (2) In
AE1, N-glycosylation motif introduced at Leu785 (corresponding
to Met858 in NBCe1-A) can be slightly N-glycosylated, consistent
with extracellular localization of this position (Popov et al., 1999).
The putative “RL2” (the non-helical TM12) between TM11
and TM13 in model A is highly hydrophilic containing 7-8
charged residues depending on specific SLC4 members. Different
studies have shown contradictory data regarding the topological
localization of residues in a specific region (888-905 in NBCe1-A
which corresponds to 815-829 in AE1) in RL2. There are both
evidences favoring and against the intracellular localization of
this region.
Evidences favoring the intracellular localization of this region
include: (1) N-glycosylation motifs introduced at 820, 821, 828
of AE1 are not subjected to N-glycosylation modification in
a cell-free translation system supplemented with microsomal
membranes (Popov et al., 1997, 1999); (2) A monoclonal
antibody directed against region 813-838 of humanAE1 can react
with the transporter only when the antibody is applied on the
cytoplamic side of the membrane, but not when applied on intact
red blood cells (Wainwright et al., 1989, 1990).
Evidences against the intracellular localization of this region
include: (1) The binding of BM to cysteine residues introduced
in region 815-829 of human AE1 is highly sensitive to inhibition
by monobromo (trimethylammonio) bimane bromide (qBBr),
which is believed to be membrane impermeant (Zhu et al., 2003);
(2) Cysteine residues introduced in region 815-829 of human
AE1 can be labeled by lucifer yellow iodoacetamide (LYIA), a
reagent that is believed to be membrane impermeant (Zhu et al.,
2003).
Interestingly, a cryo-EM structure at a resolution of 7.5Å
reveals that the TMD of human AE1 contains two V-shaped
structures arranged in opposite direction to each other in the
membrane (Figure 4; see Yamaguchi et al., 2010b). The authors
therefore proposed that these two V-shaped structures represent
two inverted repeats in AE1 TMD. Such inverted repeats are
characteristic of a number of integral membrane transporters
and channels (see review by Abramson and Wright, 2009),
such as ClC chloride channel (Dutzler et al., 2002), uracil-H+
symporter UraA (Lu et al., 2011), Na+-galactose cotransporter
vSGLT(Faham et al., 2008), Na+-leucine cotransporter LeuT
(Yamashita et al., 2005), aquaporins (Murata et al., 2000; Sui et al.,
2001), and glycerol facilitator GlpF (Fu et al., 2000). The TMDs
of these integral membrane proteins usually contain an even
number of transmembrane helices and have a pseudo two-fold
symmetry (see review by Abramson and Wright, 2009). Some
of these proteins (e.g., AQP1 and ClC) contain two half-helices
in the membrane pointing to each other in opposite direction
that play important roles in substrate binding or the formation
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FIGURE 4 | Stereo view of cryo-EM structure of the TMD of human AE1 fitted with structural elements of chloride channel ClC. The dotted lines show
the two V-shaped structures in the TMD of AE1 that fit well with helices B + C and J + K of ClC, respectively. The figure was modified from Yamaguchi et al. (2010b)
with permission.
of the ion selectivity filter (Murata et al., 2000; de Groot and
Grubmuller, 2001; Dutzler et al., 2002).
The presence of two V-shaped structures (presumably two
inverted repeats) in the cryo-EM structure of AE1 appears
to favor topological model B which has 14 transmembrane
helices (Hirai et al., 2011). Based upon the cryo-EM structure
(Yamaguchi et al., 2010b), two topological models of the TMD
human AE1 have been proposed by homology modelings, one
with the crystal structure of UraA transporter as template
(Barneaud-Rocca et al., 2013), and the other with the crystal
structure of ClC as template (Bonar et al., 2013). In both models,
the TMD of AE1 was predicted to contain 14 transmembrane
alpha helices.
ROLE OF Nt DOMAIN IN SLC4
TRANSPORTERS
The Nt domain accounts for 32-55% of the entire polypeptides
of the SLC4 family transporters. As shown in Figure 5, the
Nt domain can further be devided into multiple subdomains,
including three variable regions Nt-VR1, Nt-VR2, and Nt-
VR3 as well as two conserved regions Nt-CR1 and Nt-
CR2. The conserved regions are highly homologous with a
sequence identity of more than 33% among different SLC4
members, and 64-82% among different NCBTs. In contrast,
the variable regions usually have little similarity among
different SLC4 members and different variants of a same
SLC4 member.
Crystallography studies show that the Nt domains of the SLC4
transporters exist as homodimers (Zhang et al., 2000; Gill and
Boron, 2006; Shnitsar et al., 2013). In the fine 3-dimensional (3D)
crystal structures of the Nt domain of AE1, the variable regions
(Nt-VR1 and Nt-VR2) are largely invisible in the electron density
map, suggesting that these regions are intrinsically disordered. In
contrast, Nt-CR1 and Nt-CR2 are intertwined to form a compact
structure with a typical “α + β” fold that have segregated alpha
helices and beta strands. This compact structure represents the
core structure of the Nt domain (Figure 2C). As an intracellular
globular domain, the Nt is connected to the TMD by a highly
flexible linker as revealed by single particle electron microscopy
study (Jiang et al., 2013).
Interestingly, the Nt domains of AE1 and NBCe1 have a fold
similar with the EIIA protein (http://scop.mrc-lmb.cam.ac.uk/
scop/data/scop.b.e.cec.A.html; see review by Parker and Boron,
2013). The EIIA protein is a component of the bacterial nitrogen-
metabolic phosphotransferase system (Deutscher et al., 2006). It
has been shown that EIIA can interact with and regulate the
membrane potassium transporter TrkA in Escherichia coli (Lee
et al., 2007).
A key question is what the fundamental role of the large
intracellular Nt domain is in the ion translocation process by the
SLC4 transporters. Is the Nt just a regulatory domain involved in
functional modulation of the transporter? Is it also a part of the
ion translocation machinery (i.e., a structural component of the
ion translocation pathway) that is indispensable for the transport
activity of the proteins?
It is clear that the Nt domains of the SLC4 family transporters
are involved in the functional regulation of these transporters
in diverse manners. Firstly, the Nt domain of AE1 contains
binding sites for multiple cytoskeletal proteins, such as ankyrin-
1 (Bennett and Stenbuck, 1980; Grey et al., 2012), protein 4.1
(An et al., 1996), protein 4.2 (Toye et al., 2005; Bustos and
Reithmeier, 2006), adducin (Anong et al., 2009), etc. These
protein interactions are critical for maintaining the stability and
integrity of the plasma membrane of erythrocytes (see review
by Alper, 2009). At least, the interaction with protein 4.2 has
stimulatory effect on the transport activity of AE1 in Xenopus
oocytes (Toye et al., 2005). Secondly, the Nt domain of AE2
contains multiple structural elements important for the acute
regulation of transport activity by changes in intracellular and
extracellular pH (see discussion in “Structural variations in SLC4
transporters”). Thirdly, as will be discussed in details in section
“Structural variations in SLC4,” the Nt domains of the NCBTs
contain multiple optional structural elements (OSEs), some of
which contain binding sites for regulatory protein partners or can
modulate the intrinsic activity of the transporters.
The next question is whether the Nt domain of the SLC4
transporters is a structural component of the ion translocation
pathway that is necessary for the transport activity? Evolutionally,
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FIGURE 5 | Alignment of expression variants of SLC4 family HCO−
3
transporters. The diagram was based upon a sequence alignment with Clustal Omega
from the European Bioinformatics Institute Details. Accession numbers for the SLC4 variants are available in Supplemental Table S1. The colors denoting homology
among different SLC4 members are shown in the legend. The extreme Nt and Ct ends of different SLC4 members with identical color pattern do not denote
homology unless specified elsewhere in the main text. The dotted vertical boxes in TMD indicate the putative transmembrane helices shown in model A in Figure 2.
*Proteins containing PDZ-binding motif at the Ct end.
it appears that the large Nt domain of SLC4 transporters was
originated from a pre-existing gene independent of the one
encoding the TMD. The SLC4-like transporters from bacteria,
fungi, and plant lack the large Nt domain that is present in the
mammalian homologs. However, an isolated gene homologous
to the encoding sequence of the Nt domains of SLC4 transporters
is not identifiable in any available genome (see review by Parker
and Boron, 2013). The fact that the SLC4-like transporters from
bacteria, fungi, and plant lack the large Nt domain raises a
question whether the Nt domain is indispensable for the activities
of the mammalian SLC4 transporters.
The answer to this question appears to be different for the AEs
and NCBTs. It is now clear that the Nt domain is not necessary
for the transport activity of the anion exchangers of SLC4 family
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(at least for AE1 and AE2). Studies have shown that the transport
activity of the anion exchangers is largely retained even with
the entire Nt domain removed (Grinstein et al., 1978; Stewart
et al., 2001; Shnitsar et al., 2013). For example, by using inside-
out vesicles, it has been shown that removal of the Nt-domain
by trypsinization has no effect on the anion-exchange activity of
the membrane vesicles (Grinstein et al., 1978). Moreover, human
AE1 variant with the entire Nt domain truncated is well expressed
on the plasma membrane and contains full transport activity
in human embryonic kidney cell line HEK-293 (Shnitsar et al.,
2013). Thirdly, mouse AE2 mutant with the entire Nt domain
removed is almost fully active in mediating anion exchange
when heterologously expressed inXenopus oocytes (Stewart et al.,
2001).
A series of studies have shown that the variable region Nt-
VR1 is not necessary for the surface expression and transport
activity of NCBTs (McAlear et al., 2006; Parker et al., 2007a;
Fukuda et al., 2013; Wang et al., 2015). When heterologously
expressed in Xenopus oocytes, NBCn1-Q, a natural variant
of Slc4a7 lacking Nt-VR1, contains minimal HCO−3 transport
activity and typical Na+-conductance characteristic of NBCn1
(Wang et al., 2015). However, removal of the entire Nt domain
almost completely inactivates rat NBCe1-C when heterologously
expressed in Xenopus oocytes, although this molecular maneuver
has little effect on the surface expression of NBCe1 (McAlear
et al., 2006).
Based on a study with humanNBCe1-A, Chang et al. proposed
that the Nt domain of NBCe1, and likely other SLC4 family
members, contains a substrate entry tunnel controlling the
HCO−3 permeation of the transporter (Chang et al., 2008). By
molecular modeling based on the 3D crystal structure of AE1-
Nt, the authors claim that Glu91 and Arg298 in NBCe1-A Nt are
located in the pocket of the hypothetical substrate entry tunnel
and interact with each other by charge-charge bonding (Chang
et al., 2008). These two residues are completely conserved among
all SLC4 HCO−3 transporters. Consistent with the hypothetical
interaction between Glu91 and Arg298 are the observations that
these two residues are interchangeable without significant effect
on the activity of NBCe1 (Chang et al., 2008), whereas single
mutation on Glu91 or Arg298 markedly reduces the activity of
NBCe1-A (Igarashi et al., 1999; Chang et al., 2008).
As discussed above, the Nt domain is critical for the transport
activity the NCBTs. However, more structural and functional
studies are required to demonstrate whether the Nt domain
indeed contains a HCO−3 entry tunnel as hypothesized by Chang
et al. More recently, Shnitsar et al. disagreed with the HCO−3
entry tunnel hypothesis based upon a study with human AE1
(Shnitsar et al., 2013). The authors proposed that the Nt domain
of AE1, and likely other SLC4 family members, does not contain
a substrate entry tunnel that is essential for the transport activity
of the proteins. Their arguments include: (1) AE1 mutant carring
R293S substitution—equivalent to the natural mutation R298S in
NBCe1-A (Igarashi et al., 1999)—retains full transport activity
(Shnitsar et al., 2013); (2) As aforementioned, removal of the
entire cytoplasmic domain by either proteolytic treatment or
recombinant DNA manipulation has no effect on the transport
activities of the anion exchangers (Grinstein et al., 1978; Stewart
et al., 2001; Shnitsar et al., 2013).
ROLE OF TMD IN SLC4 TRANSPORTERS
The TMD of the SLC4 transporters is the structural component
responsible for ion translocation across the plasma membrane.
The fine 3D structure of the TMD of SLC4 transporters remains
unknown. Several cryo-EM studies have been performed to
investigate the 3D structure of AE1 (Wang et al., 1994; Yamaguchi
et al., 2010a,b; Jiang et al., 2013). However, none of these cryo-EM
structures has reached resolutions at atomic level. Due to the lack
of 3D structure information, not too much is known about the
molecular mechanisms underlying the ion translocation by the
SLC4 transporters.
Consistent with the dimerization of the Nt domain observed
in crystal structures (see discussion above in “Role of Nt domain
in SLC4 transporters”), it is generally believed that the SLC4
transporters primarily exist as dimers in the plasma membrane
(Kao et al., 2008; Yamaguchi et al., 2010b; Jiang et al., 2013).
Of course, higher degree of oligomerization (e.g., tetramer)
might also exist for the SLC4 transporters in situ in the cells.
Functional study withNBCe1 shows that eachmonomer contains
an ion translocation pathway independent of the other associated
monomer (Kao et al., 2008). Based upon the putative topological
models, mutational studies on AE1 and NBCe1 have identified
multiple putative TMs that are likely involved in the formation of
the ion translocation pathway across the plasmamembrane. Such
TMs include TM 1, 3, 5, 8, 13, and 14 (see Figure 2). As discussed
below, these TMs contain specific residues likely lining along the
cavity space of the ion translocation pathway. When replaced
with cysteine, the positions of these residues are accessible by and
sensitive to inhibition of sulfhydryl reagents, such as BM, MTS-
TAMRA, (2-aminoethyl) methanethiosulfonate (MTSEA), [2-
(trimethylammonium) ethyl] methanethiosulfonate (MTSET),
and para-chloromercuribenzene sulfonate (pCMBS).
In the sections below, we will discuss the role of the
TMD structural elements in the ion translocation by SLC4
transporters.
TM1
TM1 is likely involved in the formation of ion translocation pore.
Ala428, Ala435, Thr442 in TM1 of NBCe1-A are likely located on
the same side of the putative helical wheel of TM1, contributing
to the formation of the surface of the ion pathway (Zhu et al.,
2009). NBCe1-A mutant with Ala435 or Thr442 replaced with
cysteine is highly sensitive to inhibition by sulfhydryl reagents,
such as MTSES, MTSET, and MTSEA. Thr442 is predicted
to be located at the extracellular end of TM1 of NBCe1-A.
It is intriguing that cysteine substitution of Thr422 in AE1
(homologous to Thr442 in NBCe1-A) has no effect on the activity
of AE1 (Zhu et al., 2009).
Another line of evidence supporting the importance of TM1
in ion transport is that substitution of Ser427 with Leu in TM1
greatly reduces the intrinsic activity of NBCe1-A in Xenopus
oocytes (Dinour et al., 2004; Li et al., 2005). S427L mutation in
NBCe1 causes severe proximal renal tubular acidosis (pRTA)
in human (Dinour et al., 2004). It is hypothesized that the
substitution of Ser427 with Leu likely disturbs the orientation of
TM1 (Zhu et al., 2013).
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TM3
TM3 is likely involved in the formation of ion translocation pore.
Human AE1 mutants with Leu468 (corresponding to Val488 in
NBCe1-A) or Phe471 (corresponding to Phe491 in NBCe1-A) in
TM3 substituted by cysteine are highly sensitive to inhibition by
pCMBS, suggesting that these two residues are lining along the
ion pathway of AE1 (Barneaud-Rocca et al., 2013).
In NBCe1, two mutations of T485S and G486R in the putative
TM3 are associated with severe pRTA in human (Horita et al.,
2005; Suzuki et al., 2008). Although no effect on the membrane
trafficking of NBCe1 in MDCK cells (Suzuki et al., 2008), both
mutations cause a decrease by more then 50% in the transport
activity of NBCe1-A when heterologously expressed in HEK293
cells (Suzuki et al., 2008, 2010). The mutations T485S and G486R
likely cause great structural disturbation in the ion translocation
pathway of NBCe1.
TM4
The role of the putative TM4 in ion translocation is largely
unknown. A missense mutation L522P in TM4 of NBCe1 causes
cellular retention (Demirci et al., 2006; Suzuki et al., 2008, 2010).
Therefore, it is practically difficult to examine the effect of this
mutation on the transport function. Another missense mutation
R510H at the extracellular end of TM4 causes a decrease by∼40%
in the transport activity of NBCe1-A in human endothelial cell
EVC304 (Igarashi et al., 1999; Suzuki et al., 2010).
TM5
TM5 is likely involved in the formation of the ion translocation
pore. In human AE1, cysteine substitution at Ile528, Phe532, or
Glu535 in the putative TM5 substantially reduces the intrinsic
transport activity. Mutants L530C and I533C are sensitive to
inhibition by pCMBS, suggesting that these two residues are
lining along the ion translocation pore (Barneaud-Rocca et al.,
2013). In NBCe1-A, Asp555 (homologous to Glu535 in human
AE1) in TM5 likely plays a role in determining the ion selectivity
of the transporter (Yang et al., 2009).
Another line of evidence supportings that the putative
TM5 contributes to the formation of ion translocation pore
is that the extracellular ends of TM5 of some SLC4 members
contain a binding motif (e.g., “KLIK” in AE1 and “KKMIK”
in NBCe1) for stilbene disulfonate derivatives, such as 4,4′-
diisothiocyanodihydrostilbene-2,2′-disulfonic acid (H2DIDS),
4-acetamido-4′-isothiocyanostilbene-2,2′-disulfonic acid (SITS),
and 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS)
(Kietz et al., 1991; Okubo et al., 1994; Lu and Boron, 2007).
The stilbene reagents exhibit two phases of interaction with the
transporters, one fast reversible involving ionic interaction with
the Lys residues, the other slow irreversible involving covalent
binding with the amino group of the Lys residues (Cabantchik
and Rothstein, 1972; Bartel et al., 1989; Lu and Boron, 2007).
The presence of DIDS binding motif indicates that the
extracellular end portion of TM5 is likely involved in the
formation of the extracellular vestibule. It is proposed that the
positive charges on the sidechains of the Lys residues are involved
in the interaction with substrate anions during ion translocation
by AE1 (Cabantchik and Rothstein, 1972). Consistent with this
hypothesis, the anion permeability (assayed by SO2−4 flux) of
AE1 in human erythrocytes is reduced by blocking the positive
charges on the Lys residues either by binding of stilbene reagents
or by increasing the solution pH to convert the siechain −NH+3
to −NH2 (Cabantchik and Rothstein, 1972). However,
inconsistent with this hypothesis, another study showed that
replacing the two Lys residues in the DIDS binding motif with
the neutral Asn has no significant effect on the anion exchange
activity of mouse AE1 expressed in Xenopus oocytes, except that
the mutant AE1 loses the capacity of irreversible inhibition by
H2DIDS (Bartel et al., 1989). Additional observations seemingly
inconsistent with the above hypothesis are that extracellular
alkalinization, which would reduce the positive charges on the
Lys residues, stimulates the anion exchange activities (assayed by
Cl− flux) of AE1-3 expressed in Xenopus oocytes (Zhang et al.,
1996; Stewart et al., 2001, 2002, 2007c).
Interestingly, in human AE1, Lys539 at the outside end of
TM5 and Lys851 at the outside end of TM13 react with the same
H2DIDS molecule, suggesting that these two sites are in close
proximity (Okubo et al., 1994).
EL4
There are several line of evidences supporting the extracellular
localization of the putative fourth extracellular loop EL4. Firstly,
EL4 of AE1 contains an N-glycosylation motif “NSSA.” Note
that, AE1 is the only SLC4 member that contains N-glycosylation
motif in EL4. The N-glycosylationmotifs are located on EL3 in all
other SLC4 members. Secondly, introducing an N-glycosylation
motif into the EL4 of a human NBCe1-A variant with all
potential N-glycosylation motifs on EL3 removed results in slight
N-glycosylation of the transporter (Chen et al., 2011). Thirdly,
when replaced with cysteine residues, the positions following the
N-glycosylation site in the putative EL4 of human AE1 are highly
accessible to cysteine-reactive membrane impermeant reagent
LYIA (Tang et al., 1998).
EL4 plays a critical role in determining the electrogenicity
vs. electroneutrality of NCBTs (Chen et al., 2011). Replacing
EL4 of NBCe1 with the counterpart of the electroneutral
NBCn1 converts the electrogenic NBCe1 into electroneutral.
The opposite manipulation converts an artificial electroneutral
NCBT into electrogenic. It is proposed that EL4 is involved in
the formation of the extracellular vestibule and likely contains
binding sites for substrate ions (Chen et al., 2011).
Consistent with the functional significance of EL4 in NCBTs,
the putative EL4 of AE2 contains determinants for the pH
sensitivity of AE2 (Stewart et al., 2007a).
TM8
TM8 is likely involved in the formation of ion translocation
pore as revealed by studies with AE1 and NBCe1 (Tang et al.,
1999; McAlear and Bevensee, 2006; Barneaud-Rocca et al., 2011).
Surprisingly, TM8 appears to provide a hydrophobic surface
lining along the ion translocation pore (Tang et al., 1999;McAlear
and Bevensee, 2006). In human AE1, the hydrophobic surface
appears to consist of Ala666, Ser667, Leu669, Leu673, Leu677,
Leu680 (Tang et al., 1999). When replaced with cysteine, positions
673 and 677 of human AE1 are highly accessible to sulfhydryl
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reagents pCMBS and MTSEA (Tang et al., 1999). Consistently,
NBCe1 mutant L750C (corresponding to L677C in AE1) is highly
sensitive to inhibition by pCMBS and MTSEA (McAlear and
Bevensee, 2006).
Two additional positions (Ile684 and Ile688 in human AE1)
in IL4 immediately following the intracellular end of TM8 are
also important for ion transport. AE1 mutants with Ile684 or
Ile688 replaced by Cys are sensitive to inhibition by sulfhydryl
reagents. In some models, it is proposed that the region beyond
Ile688 (corresponding to Ile761 in NBCe1-A) forms an extended
portion of the helix of the putative TM8 (Tang et al., 1999;
Barneaud-Rocca et al., 2013; Bonar et al., 2013; Figure 2B).
A specific position in TM8, Glu681 in AE1 (corresponding to
Asp754 in NBCe1-A), is of particular interest. This Glu residue is
conserved in all three established AEs but is replaced by Asp in all
five NCBTs plus AE4. This Glu residue plays a role in determining
the substrate selectivity of AE1 and AE2 as well as the pH
sensitivity of AE2 (Sekler et al., 1995). In NBCe1-A, cysteine
substitution of Asp754 inactivates the transporter (McAlear and
Bevensee, 2006). Interestingly, replacing with Asp of this Glu in
AE1 and AE2 substantially decreases the anion exchange activity
(Sekler et al., 1995).
The significance of the Glu residue in ion translocation is
also evidenced by the effect of chemical modification by the so-
called Woodward’s reagent K on AE1 (Jennings and Anderson,
1987; Jennings and Al Rhaiyel, 1988; Jennings and Smith, 1992).
Treatment with theWoodward’s reagent K followed by reduction
with NaBH4 converts the sidechain carboxyl group of Glu
residue to alcohol. This conversion inhibits the monovalent
anion exchange by AE1 in human red blood cells (Jennings and
Al Rhaiyel, 1988).
TM13-TM14
The sequence assignments of the last two TMs (TM3 and TM14)
are basically consistent between model A and model B, except
for some minor differences in the sequence boundary (Figure 2).
These two TMs are connected by a very short extracellular loop.
Here, we discuss these two TMs together.
The significance of these two TMs in the structure and
function of the transporters is supported by cysteine scanning
mutagenesis study. In AE1, the region TM13-TM14 contains
multiple sites that, when replaced with cysteine residues, are
sensitive to inhibition by sulfydryl reagents pCMBS,MTSEA, and
MTSET to varying extent. Such sites include positions Val849 and
Val850 (corresponding to Leu923 in NBCe1-A) at the extracellular
end of the putative TM13, Ser852 and Thr853 in the putative EL7,
and Leu857 (corresponding to Ile930 in NBCe1-A), Ala858, Phe861,
Val862, and Ile863 in the putative TM14. The observations suggest
that these redidues in TM13 and TM14 is important for ion
translocation. The residues accessible to sulfhydral reagents are
likely involved in the formation of the ion translocation pore.
The inactivation of Cl−/HCO−3 exchange activity by cysteine
substitutions at any of Met833, His834, Phe836, Thr837, Gln840 in
the putative TM13, and Lys851 in the putative EL7 also support
the functional and/or structural significance of TM13 in AE1
(Zhu and Casey, 2004).
The extracellular ends of TM13 and TM14 plus the
extracellular loop in between presumably contribute to the
formation of the extracellular vestibule of the SLC4 transporters.
Consistent with this hypothesis is that, Lys539 (at the extracellular
end of TM5) and Lys851 in human AE1 (corresponding to
Lys559 in TM5 and Lys924 in TM13 of NBCe1-A) react with the
same DIDS molecule (Okubo et al., 1994), indicating that the
extracellular ends of TM5 and TM13 are juxtaposed in the 3D
structure of the transporter.
ROLE OF Ct DOMAIN IN SLC4
TRANSPORTERS
Compared to the large Nt domain and the TMD, the Ct domain
of the SLC4 HCO−3 transporters is small, accounting for only 3-
10% of the entire polypeptide, depending on specific variants of
specific SLC4 members. The anion exchangers have a fairly short
Ct tail with ∼40 residues only, whereas the longest Ct of NBCn1
variants with cassette ε (aka cassette III) contains ∼130 residues.
The initial portion of the Ct domain (Ct-CR1) right following
the TMD is highly conserved among all SLC4 family members,
whereas the last portion (Ct-VR1) of the Ct domain is highly
variable and has little similarity among different members.
The Ct domain is important for the function of SLC4
transporters in the following three perspectives. Firstly, the Ct
domain is indispensable for the functional expression, likely
the membrane trafficking, of the SLC4 transporters. Removal
of partial or the entire Ct domain greatly reduces the surface
expression of NBCe1 in Xenopus oocytes, suggesting that the
Ct domain is important for the membrane trafficking of NBCe1
(McAlear et al., 2006). Moreover, removal of the Ct portion
abolishes the Cl−/HCO−3 exchange activity of AE1 expressed in
Xenopus oocytes (Dahl et al., 2003).
Secondly, as discussed in section “Structural variations in
SLC4,” the Ct domain of some SLC4 transporters (e.g., NBCn1
andNDCBE) contains OSEs that could affect the intrinsic activity
of the transporters.
Thirdly, the Ct domains of some SLC4 family transporters
contain binding sites for protein partners. The Ct-CR1
of some members contain a conserved motif (typically
“LD[A/D][D/L][D/M/E]” enriched with acidic residues)
which is likely the binding site of carbonic anhydrase. Studies
have provided evidences showing that the Ct of AE1 interacts
with carbonic anhydrase CAII (Vince and Reithmeier, 1998,
2000). However, the interaction with CAII was questioned by
Piermarini et al who showed evidence that the binding of the Ct
of AE1, NBCe1, and NDCBE to CAII appears to be an artifact
of GST (Piermarini et al., 2007). Finally, the Ct ends of specific
variants of some SLC4 members contain typical binding motif
of PDZ-domain containing scaffold proteins (Cowan et al.,
2000; Park et al., 2002; Pushkin et al., 2003; Lee et al., 2006,
2012a, 2014; for review, see Boron et al., 2009; Parker and Boron,
2013). At least some of these interactions have been shown to
affect the function of the SLC4 transporters. Interaction with
PSD-95 stimulates the cation conductance, but has no effect
on Na+/HCO−3 cotransport activity of NBCn1 expressed in
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Xenopus oocytes (Lee et al., 2012a). Interaction with syntrophin
γ2 stimulates both the conductance and Na+/HCO−3 cotransport
activity of NBCn1 in Xenopus oocytes (Lee et al., 2014). When
expressed in mouse fibroblast 3T3 cells, the activity of NBCn2-C
is down-regulated by protein kinase A via a PDZ-protein
dependent manner (Lee et al., 2006).
STRUCTURAL VARIATIONS IN SLC4
TRANSPORTERS
All genes encoding the SLC4 family HCO−3 transporters are able
to expressmultiple variants, producing a great extent of structural
diversity in the products of these genes. Molecular clonings
during the past decades have identified a great number of
variants of these SLC4 members. As summarized in Figure 5, the
structural variations in SLC4 family products include alternative
Nts (distinct extreme Nt ends), optional cassettes, and alternative
Cts (distinct extreme Ct ends).
The alternative Nts arise from two different types of sources:
(1) transcription using distinct promoters, e.g., the generation
of alternative Nts of NBCe1-A vs. NBCe1-B (Abuladze et al.,
2000); (2) alternative splicing of cassette exons in the 5′ portion
of the messenger RNAs, e.g., the generation of alternative Nts
of NBCn1-Q vs. NBCn1-R (Wang et al., 2015). Generally, the
alternative Nts have little similarity among different SLC4 family
members and different variants of the same member.
The optional cassettes are derived from alternative splicing
of cassette exons. As shown in Figure 5, most of the known
optional cassettes are localized in the Nt and Ct domains. The
only exception is cassette ǫ of NBCe2 which is localized in the
TMD. So far, optional cassettes have been identified in NCBTs
and AE4 only.
The alternative Cts arise from alternative splicing of cassette
exons in the 3′ region of the messenger RNAs. Alternative
splicing of such cassette exons causes a frame shift, resulting in
the expression of distinct Ct ends. Note that, alternative Cts are
just identified in the variants of NCBTs, but not in those of the
anion exchangers.
The alternative Nts, the optional cassettes, and the alternative
Cts are collectively referred to as optional structural elements
(OSEs) in the present article. These OSEs play critical roles
in the functional modulation of the transporters. Functionally,
the OSEs could contain structural determinants establishing
the biophysical properties, e.g., the intrinsic activity and pH
sensitivity, of the transporters. Moreover, the OSEs could regulate
the transport function by interacting with protein partners.
Firstly, the intrinsic transport activity (or single molecular
activity) of different variants of some SLC4 members can vary
greatly, e.g., NBCe1-A vs. NBCe1-B/C (McAlear et al., 2006).
Intrinsic transport activity is an index of single molecular
transport rate (or turnover number), a fundamental biophysical
property of a transporter. Some variable regions in the Nt and Ct
domains exhibit stimulatory or inhibitory effect on the intrinsic
activity of the transporters. However, the mechanism underlying
the stimulatory or inihitory effect of the OSEs on the transport
activities largely remains to be addressed.
Secondly, the presence or absence of OSEs could affect the
pH sensitivity of the transporters, another important biophysical
property of the acid-base transporters. Anion exchangers AE2
and AE3 are highly sensitive to changes in intracellular as well as
extracellular pH, whereas AE1 is much less sensitive (Zhang et al.,
1996; Stewart et al., 2007c; for review, see Stewart et al., 2007b).
When heterologously expressed in Xenopus oocytes, cultured
Chinese hamster ovary cells, or human embryonic kidney cells
HEK293, both AE2 and AE3 are strongly activated by alkalosis
and inhibited by acidosis (Lee et al., 1991; Jiang et al., 1994; Zhang
et al., 1996; Stewart et al., 2001, 2002). As will be discussed below,
the OSEs of AE2 contains structural elements affecting the pH
sensitivity of these transporters.
Thirdly, the OSEs in the Nt and Ct domains of SLC4
transporters often contain binding sites for interacting partners.
The Nt-VR1 of eAE1 contains structural determinants for the
binding of cytoskeletal proteins. Nt-VR1 of NBCe1-B/C, NBCn1,
and NBCn2 contains binding site for IRBIT, which is an inositol
trisphosphate (IP3)-receptor (IP3R) binding protein released
with IP3 (Ando et al., 2003). Cassette β (aka cassette II) of NBCn1
contains binding site for calcineurin Aβ (CnAβ). Finally, as just
discussed in the previous section, the Ct ends of variants of
several SLC4 members contain binding motif for PDZ-domain
containing scalfold proteins. Some of these protein interactions
have great effect on the activities of the transporters.
In the following sections, we will discuss the structural
variations and their potential consequences on the functions of
each of the SLC4 family HCO−3 transporters.
AE1 (SLC4A1)
AE1 (aka Band 3), was the first to be cloned in the SLC4
family, originally frommurine spleen (Kopito and Lodish, 1985),
and then from human erythrocytes (Lux et al., 1989). SLC4A1
encoding AE1 has two alternative promoters (Sahr et al., 1994;
Schofield et al., 1994), regulating the expression of two variants
with alternative Nts: the erythrocyte variant eAE1 (Kopito and
Lodish, 1985; Lux et al., 1989) and the kidney variant kAE1
(Kollert-Jöns et al., 1993). The initial portion (Nt-VR1, 65 aa
in human) of eAE1 is absent in kAE1. AE1 variants have no
structural variation in the TMD and Ct domain.
Nt-VR1 appears to be intrinsically disordered and is largely
invisible in the crystal structures of the Nt domain of AE1
(Zhang et al., 2000; Shnitsar et al., 2013). Nt-VR1 is dispensable
for the anion-exchange activity of AE1, as kAE1 lacking the
whole Nt-VR1 is active in mediating Cl−/HCO−3 exchange when
heterologously expressed in Xenopus oocytes (Bruce et al., 1997;
Fry et al., 2012). Actually, as discussed in section “Role of Nt
domain in SLC4 transporters,” the whole Nt domain is not
necessary for the transport activity of AE1. The role of Nt-VR1
in the structure and function of AE1 remains to be addressed.
AE2 (SLC4A2)
In mouse, five AE2 variants (AE2a, AE2b1, AE2b2, AE2c1, and
AE2c2) have been identified, whereas in human, only the first
three have been identified. The five mouse AE2 variants are
derived from three different promoters, designated as a, b, and c
(Wang et al., 1996; Lecanda et al., 2000; Medina et al., 2000).
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As shown in Figure 5, variants AE2a (first 17 aa), AE2b1 (first
3 aa), and AE2b2 (first 8 aa) are only slightly different from each
other in the initial Nt ends, whereas AE2c1 is truncated in the Nt
by 198 aa compared to AE2a. AE2c2 contains an additional 32
residues at the Nt end compared to AE2c1. Except for the initial
Nt ends, AE2 variants have no additional structural variations in
other regions.
The activities of AE2 variants are highly sensitive to acute
changes in intracellular as well as extracellular pH. For example,
mouse AE2a, AE2b1, AE2b2, and AE2c1 are all steeply sensitive
to regulation by pH when heterologously expressed in Xenopus
oocytes (Kurschat et al., 2006). Compared to the other AE2
variants, the activation of AE2c1 requires more alkaline pH.
These observations suggest that the optional region omitted in
the Nt of AE2c1 contains determinants for the difference in
pH sensitivities of different AE2 variants. Further studies have
shown that, removal of the first 99 residues of Nt-VR1 of mouse
AE2a has little effect on the pH sensitivity of AE2-mediated
anion-exchange activity (Zhang et al., 1996; Stewart et al., 2001;
Kurschat et al., 2006). The key structural element responsible for
the differences in the pH sensitivities of AE2a and AE2c1 lies in
the Glu-rich sequence 120-150 (Kurschat et al., 2006).
Note that, although not discussed here, the non-variable
region of Nt domain and the TMDof AE2 also contains structural
determinants for the pH sensitivity (Stewart et al., 2002, 2007a,c;
for review, see Alper, 2009).
AE3 (SLC4A3)
SLC4A3 encoding AE3 has two alternative promoters,
responsible for the expression of two full-length variants:
bAE3 and cAE3. bAE3, literally meaning “the brain variant,”
is expressed under the control of the distal promoter, whereas
cAE3 (literially “the cardiac variant”) is expressed under the
control of the proximal promoter (Yannoukakos et al., 1994).
Note that the non-menclatures of bAE3 and cAE3 variants are
only historically meaningful as they are also expressed in other
tissues, e.g., bAE3 in the intestine (Alrefai et al., 2001), bAE3
and cAE3 in the kidney (Kampik et al., 2014). The first 271 aa of
bAE3 is unique compared to the first 73 aa of cAE3. Except for
the initial Nt ends, the AE3 variants have no additional structural
variations in other regions.
As shown in Figure 5, the first 270 aa of the Nt of bAE3 is
unique compared to the first 73 aa of cAE3. Note that, the Nt-
VR1 (the red plus yellow regions) of bAE3 shares high sequence
homology with that of AE2a. Moreover, the boundary of exons
encoding Nt-VR1 of bAE3 is identical to that of AE2a. These facts
suggest that the Nt-VR1 of AE2a and bAE3 have been elvoved
from a common ancestor. Except for the difference in the extreme
Nt ends, no OSE has been identified in other regions of AE3. The
functional consequence of structural variation in AE3 remains
unclear.
AE4 (SLC4A9)
Compared to the other eight members of SLC4 family HCO−3
transporters, AE4 is less well characterized. Several AE4 variants
have been reported in GenBank, shown in Figure 5 are only
two variants: AE4a and AE4b originally identified from rabbit
(Tsuganezawa et al., 2001). Other variants are not included
here as they are not well characterized and even questionable,
e.g., containing large deletion in the TMD. Due to alternative
usage of a cryptic splicing acceptor site at the 5′ portion of
the coding exon, AE4b lacks a 16-aa cassette (cassette ε) in Nt-
VR3 compared to AE4a. Although not identified, DNA sequence
alignment shows that the potential cryptic splicing site for this
cassette is conserved in all five genes encoding the NCBTs.
NBCe1 (SLC4A4)
NBCe1 was originally identified from the renal proximal tubule
of salamander (Boron and Boulpaep, 1983). It was the first to
be cloned among the five NCBTs (Romero et al., 1997). SLC4A4
encoding NBCe1 has two alternative promoters and two cassette
exons. SLC4A4 is able to express at least five different variants,
namely, NBCe1-A through -E. NBCe1-A/D are expressed under
the control of the proximal promoter, whereas NBCe1-B/C/E are
expressed under the control of the distal promoter.
The five NBCe1 variants contain three structural variations:
the alternative Nts, optional cassette α (aka cassette I) in the Nt
domain, and the alternative Cts. As shown in Figure 5, the initial
41 aa of Nt-VR1 of NBCe1-A/D is distinct from the initial 85 aa
of NBCe1-B/C/E due to alternative transcription using different
promoters of SLC4A4 (Abuladze et al., 2000). The 9 aa optional
cassette α in Nt-VR2 arises from alternative splicing of the 3′
portion of exon 6 of SLC4A4 (Liu et al., 2011). The last 61 aa of
the Ct domain of NBCe1-C is unique compared to the last 46
aa of the Ct domain of NBCe1-A/B/D/E. The differences in the
alternative Cts of NBCe1 are due to alternative splicing of exon
24 of SLC4A4 (Bevensee et al., 2000). This exon 24 contains a
stop codon. Inclusion of exon 24 in the messenger RNAs results
in the production of the short Ct of NBCe1-A/B/D/E. Exclusion
of exon 24 in the messenger RNA results in the expression of the
long Ct of NBCe1-C.
The differences in the initial portion of Nt-VR1 are
particularly important for the functional modulation of NBCe1.
Firstly, this region plays a critical role in establishing the intrinsic
activity of NBCe1 variants. Specifically, the unique region in Nt-
VR1 of NBCe1-A is stimulatory, whereas the unique region in
Nt-VR1 of NBCe1-B/C is inhibitory to the intrinsic activity of the
transporters (McAlear et al., 2006). The stimulatory or inhibitory
effect of Nt-VR1 is so profound that the intrinsic activity of
NBCe1-A is about 4-5 times higher than those of NBCe1-B/C
when heterologously expressed in Xenopus oocytes (McAlear
et al., 2006). However, it remains mystic about the molecular
mechanisms underlying the stimulatory vs. inhibitory effects of
unique regions of Nt-VR1 of NBCe1 variants.
Secondly, the unique region of Nt-VR1 of NBCe1-
B/C contains structural determinants for the binding of
IRBIT (Shirakabe et al., 2006). IRBIT interacts with inositol
trisphosphate (IP3)-receptor (IP3R) but is released from the
latter upon the binding of IP3 to IP3R (Ando et al., 2003). IRBIT
can substantially stimulate the transport activity of NBCe1-B/C
to about the same level of the activity of NBCe1-A (Shirakabe
et al., 2006; Thornell et al., 2010; Lee et al., 2012b). In NBCe1-B,
the structural determinant essential for the binding of IRBIT
is located in the first 19 aa of Nt-VR1 and is distinct from the
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structural determinant for the auto-inhibitory effect of Nt-VR1
(Lee et al., 2012b).
The functional consequence of cassette I in Nt-VR2 remains to
be investigated. The difference in the Ct ends of NBCe1 variants
has no significant effect on the transport activity when expressed
in Xenopus oocytes (McAlear et al., 2006). Finally, the long Ct of
NBCe1-C contains a typical PDZ-binding motif.
NBCe2 (SLC4A5)
NBCe2 was originally cloned from human testes (Pushkin et al.,
2000). It is the second established electrogenic Na+/HCO−3
cotransporter of the SLC4 family. SLC4A5 encoding NBCe2
contains two alternative promoters (Stütz et al., 2009; Fukuda
et al., 2013). So far, seven NBCe2 variants have been reported
in GenBank, designated as NBC4a-g (referred to as NBCe2-
a through -g here). Shown in Figure 5 are only NBCe2-a,
-c, and -g. NBCe2-c and NBCe2-g have been functionally
characterized (Sassani et al., 2002; Virkki et al., 2002; Fukuda
et al., 2013). Although not tested, NBCe2-a likely represent an
active transporter. As discussed elsewhere (Parker and Boron,
2013; Romero et al., 2013), the other four NBCe2 variants are
questionable as they contain unusual deletions in the TMD.
The three NBCe2 variants shown in Figure 5 contain two
OSEs: (1) Nt-VR1 that is present in NBCe2-a/c and truncated
in NBCe2-g; (2) cassette ε of 16 aa in TMD that is present in
NBCe2-a and absent in NBCe2-c and -g. Cassete ε is derived
from alternatives splicing of cassette exon 27 (see review by
Parker and Boron, 2013). Reminiscent of kAE1, NBCe2-g lacking
the entire Nt-VR1 is well expressed on the plama membrane
and functionally active (Fukuda et al., 2013; Wang et al., 2015),
demonstrating that Nt-VR1 is dispensable for the transport
activity of NBCe2. The functional significance of cassette ε
remains unclear.
NBCn1 (SLC4A7)
NBCn1 was the first characterized electroneutral Na+/HCO−3
cotransporter (Pushkin et al., 1999; Choi et al., 2000). SLC4A7
encoding NBCn1 has two alternative promoters and as many
as six major cassette exons (Liu et al., 2013a; Wang et al.,
2015). So far, 18 full-length NBCn1 variants have been identified,
designated as NBCn1-A through -R. In addition, SLC4A7 is able
to express two types of special variants containing just the Nt
domain: NBCn1-e/g and NBCn1-c/h (Liu et al., 2013a). Herein,
the term “full-length” is used to refer to the variants of SLC4
members that contain all three major domains of Nt, TMD, and
Ct, differing from the product like NBCn1-e/g containing just the
isolated Nt domain.
These NBCn1 variants have four different types of initial
Nt ends, commonly referred to as “MEAD,” “MERF,” “MIPL,”
or “MDEL,” each representing the first four residues of the
corresponding Nt (Pushkin et al., 1999; Choi et al., 2000; Liu
et al., 2013a; Wang et al., 2015). MEAD-NBCn1 (including
full-length NBCn1-B/C/D/E/G/H/I/O/P and NBCn1-e/g and -
c/h containing just the isolated Nt domain) is expressed under
the control of the distal promoter, whereas MERF-NBCn1
(including NBCn1-A/F/J/K/L/M/N), MIPL-NBCn1 (NBCn1-R),
and MDEL-NBCn1 (NBCn1-Q) are expressed under the control
of the proximal promoter of SLC4A7 (Liu et al., 2013a; Wang
et al., 2015). As shown in Figure 5, the initial Nt of MEAD-,
MERF-, and MIPL-NBCn1 are just slightly different from each
other, whereas MDEL-NBCn1 is truncated by Nt-VR1 compared
to the other three types of NBCn1 variants.
In addition to the differences in the initial Nt ends, NBCn1
contains four optional cassettes: cassettes α, β, and γ (aka
cassettes I, II, and IV) in the Nt domain and cassette ζ (aka
cassette III) in the Ct domain. Cassette β of NBCn1 is the largest
(123 aa in rodent and 124 aa in human) among all reported
optional cassettes in the SLC4 family HCO−3 transporters.
Cassette α is present in NBCn1-A/B/D/E/F/G/J/N/P/Q and
NBCn1-e/g. Cassette β is present in NBCn1-A/B/C/D/K/H/R
and NBCn1-c/h. Cassette γ is present in NBCn1-M/N/O/P.
Cassette ζ is present in NBCn1-C/D/G/I/J/L/M/N/O/P/Q.
Except for NBCn1-e/g and -c/h with just the Nt domain, all
full-legnth NBCn1 variants have the same extreme Ct ends.
The structural differences in the initial Nts ofMEAD-,MERF-,
and MIPL-NBCn1 appear to have no substantial effect on the
intrinsic activity of NBCn1 (Liu et al., 2013a; Wang et al.,
2015). NBCn1-Q lacking the entire Nt-VR1 has only minimal
transport activity minimal in Xenopus oocytes although it can
be sufficiently expressed on the plasma membrane, suggesting
that Nt-VR1 is important for the intrinsic activity of NBCn1
(Wang et al., 2015). As indicated in Figure 5, the Nt-VR1 of
NBCn1 is modestly homologous to the Nt-VR1 of NBCe1-B/C.
Similar to NBCe1-B/C, the Nt-VR1 of NBCn1 likely contains
binding determinants for IRBIT, as evidenced by a preliminary
observation that coexpressing IRBIT increases the functional
expression of rat NBCn1 in Xenopus oocytes (Parker et al.,
2007b).
Among the optional cassettes, cassette α appears to have no
significant effect on the intrinsic activity of NBCn1, whereas
cassettes β, γ, and ζ have stimulatory effects on the intrinsic
activity of NBCn1 heterologously expressed in Xenopus oocytes
(Liu et al., 2013a). Cassette β is of particular interest for the
functional regulation of NBCn1 in asmuch as it contains binding
determinants for calcineurin CnAβ (Parker and Boron, 2008),
a Ca2+-calmodulin activated Ser/Thr phosphatase (Rusnak and
Mertz, 2000). The structural element essential for the binding of
CnAβ lies in the last 57 residues of cassette β of NBCn1 (Parker
and Boron, 2008). The binding of CnAβ stimulates the activity
of NBCn1 in the vascular smooth muscle cells (Danielsen et al.,
2013), where NBCn1 plays a critical role in the regulation of
intracellular pH (Boedtkjer et al., 2011).
NBCn2 (SLC4A10)
SLC4A10 encoding NBCn2 contains three alternative promoters
(at least in rat Slc4a10) and as many as seven cassette exons (Liu
et al., 2013b; Wang et al., 2015). So far, SLC4A10 is known to
express 15 “full-length” NBCn2 variants (NBCn2-A through -N,
plus rb3NCBE) as well as a specific variant rb7NCBE containing
just the Nt domain. These variants have three different initial Nt
ends starting with MEIK- (NBCn2-A through -D plus rb3NCBE
and rb7NCBE), MCDL- (NBCn2-E through -J), and MHAN-
NBCn2 (NBCn2-K through -N), respectively. MEIK-NBCn2
is expressed under the control of the most distal promoter
Frontiers in Physiology | www.frontiersin.org 13 December 2015 | Volume 6 | Article 355
Liu et al. SLC4 Bicarbonate Transporters
P1. MCDL-NBCn2 could be expressed from either the middle
promoter P2 or the proximal promoter P3. Finally, MHAN-
NBCn2 is expressed under the control of the middle promoter
P2 (Wang et al., 2015).
The initial Nt ends of MEIK- and MCDL-NBCn2 are just
slightly different from each other. Note that, there is a species-
specific variation in the Nt of the variants designated as
“MCDL-NBCn2” here (Liu et al., 2013a). The initial Nt of the
corresponding mouse variants start with “MQPG” rather than
“MCDL.” Mouse MQPG-NBCn2 variants are truncated by 13
residues compared to the rat counterparts (Liu et al., 2013b).
The structural variations in the initial Nts of MEIK- vs. MCDL-
vs. MQPG-NBCn2 have no significant effect on the functional
expression of NBCn2 expressed in Xenopus oocytes (Liu et al.,
2013b). MHAN-NBCn2 is truncated by the entire Nt-VR1 plus
about half of Nt-CR1 compared to other three full-length NBCn2
variants. This truncation causes severe cellular retention of
NBCn2 when heterologously expressed in mammalian cell line
neuro-2A (Wang et al., 2015).
The Nt domain of NBCn2 contains one major optional
cassettes, i.e., cassette γ (aka cassette A in NBCn2). Cassette
γ is present in NBCn2-B/D/F/H/J/L/N and “rb3NCBE.” The
functional consequence of the presence vs. absence of cassette γ
in NBCn2 remains unclear. In addition, the Nt domain of NBCn2
contains one minor variation, i.e., the optional inclusion of a
single residue Ala256 (numbering according to MEIK-NBCn2)
due to alternative usage of a cryptic splicing acceptor site. The
optional inclusion of this single Ala residue appears to be random
and presumably has no significant effect on the structure and
function of NBCn2.
In the Ct domain, NBCn2 contains an optional cassette ζ (aka
cassette C, 39 aa in length; see Wang et al., 2015). Cassette ζ is
absent in NBCn2-M and -N. The functional consequences of the
presence vs. absence of cassette ζ on the structure and function of
NBCn2 remain to be investigated.
As shown in Figure 5, the known NBCn2 variants contain
five different Ct ends: (1) NBCn2-C/D/G/H/K/L/M/N have the
longest Ct with a typical PDZ binding motif “ECTL”; (2) NBCn2-
A/B/E/F have a short Ct ending with “SPSS”; (3) NBCn2-I/J have
a short Ct ending with “RS” (Liu et al., 2013b); (4) The Ct of
rb3NCBE is truncated by the Ct-VR1; (5) rb7NCBE with just the
Nt domain contains a unique Ct end. The differences in the first
three types of Ct ends arise from the alternative splicing of the so-
called cassette B (the exon right after the one encoding cassette ζ)
of SLC4A10 (Liu et al., 2013b), whereas the truncation in the Ct of
rb3NCBE is due to the omission of cassettes B andC plus the exon
procedding cassette ζ (see review by Parker and Boron, 2013). The
functional relevance of the variations in the Ct ends of NBCn2
remains to be elucidated.
Finally, it is worth to note that, when co-expressed, the isolated
Nt domain of NBCn2 is able to interact with MHAN-NBCn2 and
promotes the membrane trafficking of the latter in heterologous
expression system (Wang et al., 2015).
NDCBE (SLC4A8)
SLC4A8 encoding NDCBE contains two alternative promoters
and as many as four cassette exons (Parker et al., 2008). So far,
five full-length NDCBE variants, NDCBE-A through -E, have
been identified. In addition, SLC4A8 is able to produce a specific
variant “THYMU3021755” with just the isolated Nt domain.
NDCBE-A/B and “THYMU3021755” are expressed under the
control of the proximal promoter, whereas NDCBE-C/D/E are
expressed under the control of the distal promoter of SLC4A8.
Except for the variations in the Nt and Ct ends, no optional
cassette has been identified in the known NDCBE variants.
As shown in Figure 5, the known NDCBE variants have
three different Nt ends: (1) NDCBE-A/B and THYMU3021755
containing the isolated Nt domain have a unique Nt end of 16
aa compared to NDCBE-E; (2) NDCBE-C/D are truncated at the
Nt by 54 residues compared to NDCBE-A/B; (3) NDCBE-E has
a unique Nt end of 43 aa compared to NDCBE-A. The structural
variation in the Nt domain appears to have no significant effect
on the functional expression of NDCBE in Xenopus oocytes
(Parker et al., 2008).
The NDCBE variants have three different Ct ends: (1) The last
66 residues of the full-length NDCBE-A/C is unique compared
to NDCBE-B/D/E; (2) The last 17 residues of NDCBE-B/D/E
is unique compared to NDCBE-A/C; (3) The last 15 residues
of THYMU3021755 with the isolated Nt domain is unique
compared to the full-length variants. The differnce in the Ct ends
of the full-length NDCBE arises from alternative splicing of exon
25 of SLC4A8 (Parker et al., 2008). The unique 17 aa of the
Ct end of NDCBE-B/D has inhibitory effect on their functional
expression in Xenopus oocytes (Parker et al., 2008).
CONCLUDING REMARKS
Since the identification of the erythrocytic AE1 more than four
decades ago, our knowledge about the SLC4 family HCO−3
transporters have been expanded greatly. The molecular cloning
of a series of expression variants of the SLC4 genes has
revealed many OSEs in the transporters. Some of these OSEs
have been demonstrated to have important structural and
functional relevances. Following the determination of the gross
membrane organization of the SLC4 transporters, great advances
have been made in understanding the topological structure
of the TMD, although some major issues remain unsettled.
Based upon the proposed topological models, mutational and
functional studies have identified a number of structural elements
important for the function of the trasnsporters. Particularly,
some key transmembrane segments have been identified that are
likely involved in the formation of ion translocation pathway.
Moreover, as have been extensively reviewed elsewhere (Stewart
et al., 2007b; Parker and Boron, 2013), genetics studies have
identified a series of mutations in the SLC4 transporters,
particularly in AE1 and NBCe1. The results from these
studies shed important light for understanding the mechanism
underlying the ion translocation by the HCO−3 transporters.
In future studies on the structure and function of the SLC4
transporters, the following issues are of particular interest to
investigators. Firstly, although the crystal structure of the soluble
Nt domain of some members have been reported, some major
issues remain to be addressed regarding the role of the large Nt
domain in the ion translocation. Why the Nt domains of AEs are
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not necessary, whereas those of NCBTs are indispensible for the
ion transport activities? Except for their regulatory roles for the
transporters, are the Nt domains also directly involved in the ion
translocation process, e.g., being a part of the ion translocation
pathway as suggested by Chang et al. (2008)?
Secondly, the fine 3D structure of the TMD of the SLC4
transporters remains mystic. Cryo-EM could be a promising
strategy to resolve this issue, given the great progresses in
the development of cryo-EM technology and its application in
determining the near-atomic level structures of highly complex
macromolecules including integral membrane proteins during
the past years (Kühlbrandt, 2014). Red blood cell membrane
could be an ideal system for cryo-EM study due to the extremely
high abudance of AE1 in erythrocytic membrane.
Thirdly, as secondary active transporters, the molecular
mechanism underlying the substrate coupling during ion
transport by SLC4 proteins remains mystic. It remains unclear
how the stoichiometry of the SLC4 transporters is determined.
The stoichiometry of some electrogenic NCBTs, e.g., NBCe1-
A, can be switched between 3:1 and 2:1 (HCO−3 over Na
+)
depending on the expression systems or in response to specific
stimulus (Gross et al., 2001). What is the mechanism underlying
such conversion of the transport stoichiometry?
Fourthly, what is the structural basis for the differences in
the Na+-dependence vs. Na+-independence of the ion transport
by the SLC4 proteins? Are there fundamental differences in
the structures of TMDs (e.g., the number and orientation of
transmembrane helices in the topology structure) between the
AEs and NCBTs? Is NDCBE (SLC4A8) a hybrid of anion
exchanger and Na+/HCO−3 cotransporter?
Answering these questions will require studies involving
structural, biophysical, and functional approaches. It is no
doubt that the knowledge about the structure and function of
the SLC4 family transporters derived from these studies will
greatly enhance our understanding about the physiology of these
proteins. The knowledge about structure and function will also
be of high relevance to clinical and pharmaceutical studies.
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